Non Hodgkin Lymphoma Clinical Trial

Clinical Trial Finder Non Hodgkin Lymphoma Trials

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

See Locations Near You

Summary

The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Subject has been enrolled and dosed in an ongoing venetoclax study and continues to tolerate and derive benefit from the study drug.
Male subject agrees to refrain from sperm donation.
Female subjects must not be pregnant or breastfeeding.

Exclusion Criteria:

- None.

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 3

Estimated Enrollment:

165

Study ID:

NCT03844048

Recruitment Status:

Active, not recruiting

Sponsor:

AbbVie

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 56 Locations for this study

See Locations Near You

University of Arizona Cancer Center - Tucson /ID# 210548
Tucson Arizona, 85724, United States
UCLA Santa Monica Hematology Oncology /ID# 210551
Los Angeles California, 90095, United States
Ingalls Memorial Hosp /ID# 210553
Harvey Illinois, 60426, United States
Dana-Farber Cancer Institute /ID# 215360
Boston Massachusetts, 02215, United States
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 231132
Ann Arbor Michigan, 48109, United States
Dartmouth-Hitchcock Medical Center /ID# 210555
Lebanon New Hampshire, 03756, United States
Swedish Cancer Institute /ID# 213120
Seattle Washington, 98104, United States
Royal Prince Alfred Hospital /ID# 239557
Camperdown New South Wales, 2050, Australia
St George Hospital /ID# 225589
Kogarah New South Wales, 2217, Australia
Liverpool Hospital /ID# 225591
Liverpool New South Wales, 2170, Australia
Peter MacCallum Cancer Ctr /ID# 210559
Melbourne Victoria, 3000, Australia
Fiona Stanley Hospital /ID# 239480
Murdoch Western Australia, 6150, Australia
Perth Blood Institute Ltd /ID# 225592
Nedlands Western Australia, 6009, Australia
Medizinische Universitaet Graz /ID# 223817
Graz Steiermark, 8010, Austria
UCL Saint-Luc /ID# 224327
Woluwe-Saint-Lambert Bruxelles-Capitale, 1200, Belgium
CHUQ- Hôpital de l'Enfant-Jesus /ID# 224616
Quebec City Quebec, G1J 1, Canada
Rigshospitalet /ID# 224213
Copenhagen Ø Hovedstaden, 2100, Denmark
Aarhus University Hospital /ID# 224214
Aarhus N Midtjylland, 8200, Denmark
HCL - Hopital Lyon Sud /ID# 213508
Pierre Benite CEDEX Rhone, 69495, France
CHU Grenoble - Hopital Michallon /ID# 240497
La Tronche , 38700, France
General Hospital of Athens Laiko /ID# 224087
Athens Attiki, 11527, Greece
General Hospital of Thessaloniki George Papanikolaou /ID# 224088
Thessaloniki , 57010, Greece
Queen Mary Hospital /ID# 224944
Hong Kong , 99907, Hong Kong
Beaumont Hospital /ID# 225165
Beaumont Dublin, D09 X, Ireland
Kobe City Medical Center General Hospital /ID# 241518
Kobe-shi Hyogo, 650-0, Japan
National Hospital Organization Mito Medical Center /ID# 241986
Higashi Ibaraki-gun Ibaraki, 311-3, Japan
Okayama Medical Center /ID# 241517
Okayama-shi Okayama, 701-1, Japan
National Cancer Center Hospital /ID# 241516
Chuo-ku Tokyo, 104-0, Japan
Samsung Medical Center /ID# 240882
Seoul , 06351, Korea, Republic of
Centro de Investigacion Clínica Chapultepec SA de CV /ID# 227018
Morelia Michoacan, 58260, Mexico
Hospital Universitario Dr. Jose Eleuterio Gonzalez /ID# 227017
Monterrey Nuevo Leon, 64460, Mexico
Aotearoa Clinical Trials /ID# 225596
Papatoetoe Auckland, 2025, New Zealand
North Shore Hospital /ID# 225597
Takapuna Auckland, 0622, New Zealand
Wellington Regional Hospital /ID# 225593
Newtown Wellington, 6021, New Zealand
Pratia MCM Krakow /ID# 218561
Krakow Malopolskie, 30-72, Poland
Instytut Hematologii i Transfuzjologii /ID# 225478
Warszawa Mazowieckie, 02-77, Poland
SP ZOZ Zespol Szpitali Miejskich w Chorzowie /ID# 225474
Chorzow Slaskie, 41-50, Poland
IPO Lisboa FG, EPE /ID# 225072
Lisboa , 1099-, Portugal
Federal State Budgetary Scientific Institution N.N. Blokhin /ID# 225194
Moscow Moskva, 11547, Russian Federation
Regional Oncological Dispensary /ID# 225195
Penza Penzenskaya Oblast, 44007, Russian Federation
Hospital Universitario Fundacion Jimenez Diaz /ID# 225476
Madrid , 28040, Spain
Skane University Hospital Lund /ID# 224747
Lund Skane Lan, SE 22, Sweden
China Medical University Hospital /ID# 224945
Taichung , 40447, Taiwan
National Taiwan University Hospital /ID# 224946
Taipei City , 100, Taiwan
Ankara Univ Medical Faculty /ID# 225043
Ankara , 06590, Turkey
Istanbul University Istanbul Medical Faculty /ID# 225045
Istanbul , 34093, Turkey
Vehbi Koc vakfi Amerikan Hasta /ID# 225046
Istanbul , 34365, Turkey
Municipal Non-Profit Enterprise City Clinical Hospital 4 of Dnipro City Council /ID# 240575
Dnipro , 49102, Ukraine
Leicester Royal Infirmary /ID# 240468
Leicester England, LE1 5, United Kingdom
University Hospital Southampton NHS Foundation Trust /ID# 225161
Southampton Hampshire, SO16 , United Kingdom
Blackpool Teaching Hospitals NHS Foundation Trust /ID# 225163
Blackpool , FY3 8, United Kingdom
The Clatterbridge Cancer Centre NHS Foundation Trust /ID# 218736
Liverpool , L7 8Y, United Kingdom
University College London Hospitals NHS Foundation Trust /ID# 240467
London , NW1 2, United Kingdom
King's College Hospital NHS Foundation Trust /ID# 218735
London , SE5 9, United Kingdom
University Hospital Plymouth NHS Trust /ID# 218731
Plymouth , PL6 5, United Kingdom
The Royal Wolverhampton NHS Trust /ID# 225164
Wolverhampton , WV10 , United Kingdom
Load More

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 3

Estimated Enrollment:

165

Study ID:

NCT03844048

Recruitment Status:

Active, not recruiting

Sponsor:


AbbVie

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Clinical Trials Test State-of-the-Art Cancer Treatments
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider